Cancer
PG500 Series Presented at the AACR Annual Meeting in San Diego
Published in Medical Letter on the CDC and FDA, May 4th, 2008
Progen Pharmaceuticals Limited (NASDAQ:PGLA) announced that it had presented new data on its patented PG500 series of compounds at the annual American Association for Cancer Research (AACR) meeting being held in San Diego. The meeting brings together approximately 17,000 participants from around the world to discuss new and significant advances in the knowledge surrounding the causes, diagnosis, treatment and prevention of cancer.
The data presented shows that this series of heparan sulfate mimetic compounds have very strong inhibition of angiogenesis and metastasis and strong anti-tumor activity in some aggressive tumor models. The data firmly supports the continued...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Clinical Trial Research
Risk of death from rofecoxib in some trials may have been misrepresented by study sponsor - Cancer
Data on cancer described by A.L. Mayburd et al - RF Surgical Systems, Inc.
Virginia Commonwealth University Medical Center Adopts Cutting-Edge Technology to Enhance Patient Safety in the - Dementia Therapy
Studies from Yale University, Department of Psychiatry update current data on dementia therapy - HIV/AIDS Therapy
Studies from University of Southern California reveal new findings on HIV/AIDS therapy - Life Sciences
Research from Food & Drug Administration provides new data on life sciences - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
